Other functions - biomarker testing o patients

Ended Purchase Order Awarded

Contract number
HHSN275201700229P
Awardee
Awarding agency
Obligated
$44,280

Award facts

Opportunity
Contract value 100% obligated
$44,280.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $44,280 purchase order to Myriad RBM, Inc., a subsidiary of Myriad Genetics Inc., to provide biomarker testing on patients. The contract has a period of performance from February 8, 2017 to March 17, 2017 and utilizes a firm fixed price payment structure. To be performed in Bethesda, Maryland, this contract supports NIH's efforts to advance child health and development through medical research by providing biomarker data to inform various studies and clinical trials.

Quick answers

Who was awarded contract HHSN275201700229P?

HHSN275201700229P was awarded to Myriad Rbm, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on February 8, 2017.

How much is contract HHSN275201700229P worth?

The government has obligated $44,280 on HHSN275201700229P.

Was contract HHSN275201700229P competed?

The extent of competition for HHSN275201700229P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award